TG Therapeutics | TGTX - Trade Creditors


TG Therapeutics reported $61.64M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Alaunos Therapeutics USD 843K 34K Sep/2025
Amgen USD 20.89B 1.25B Dec/2025
Ardelyx USD 19.24M 845K Dec/2025
Arrowhead Research USD 32.94M 15.26M Dec/2025
Bayer EUR 7.08B 700M Dec/2025
Biogen USD 358.5M 73.5M Mar/2026
Corcept Therapeutics USD 40.44M 6M Dec/2025
Curis USD 5.61M 1.52M Dec/2025
Gilead Sciences USD 715M 93M Dec/2025
Infinity Pharmaceuticals USD 1.5M 433K Jun/2023
J&J USD 10.46B 1.53B Mar/2026
Karyopharm Therapeutics USD 4M 1.39M Dec/2025
Novartis USD 4.46B 99M Dec/2025
Novavax USD 24.58M 9.35M Dec/2025
PTC Therapeutics USD 45.49M 8.87M Dec/2025
Puma Biotechnology USD 6.39M 962K Sep/2025
Regeneron Pharmaceuticals USD 1.03B 4.81B Mar/2026
Roche Holding CHF 5.78B 1.27B Dec/2025
TG Therapeutics USD 61.64M 72.38M Sep/2025
Verastem USD 12.45M 2.56M Dec/2025
Vertex Pharmaceuticals USD 3.43B 600.9M Dec/2025